IP Verse

Stada Arzneimittel competitive analysis

Latest oppositions filed by Stada Arzneimittel

Explore patent oppositions filed by Stada Arzneimittel against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026
Patent NumberTitleApplicantOpposition Date
EP4188389
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 17, 2026
EP3676404
Methods Of Selecting A Treatment For Cancer PatientsNOVARTISJun 3, 2026
EP3570840
Combinations Of Cabozantinib And Atezolizumab To Treat CancerEXELIXISDec 19, 2025
EP3861346
Biomarkers For A Therapy Comprising A Sorafenib CompoundEISAI R&D MANAGEMENTOct 8, 2025
EP3539540
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 18, 2025
EP4218732
Tablets Comprising Eltrombopag OlamineNOVARTISAug 5, 2025
EP4125903
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025
EP2662094
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025
EP3781132
Apixaban FormulationsBRISTOL MYERS SQUIBBDec 19, 2024
EP3628319
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 13, 2024

Latest patents of Stada Arzneimittel opposed by its competitors

Explore Stada Arzneimittel's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 16, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3324936
Sep 28, 2022Method For Producing A Bortezomib Ester Solution6
EP3324937
Aug 17, 2022Ready-To-Use Bortezomib Solution7
EP1591105
May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations7
EP2233127
May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations11

Latest PTAB cases involving Stada Arzneimittel

Discover the latest PTAB cases involving Stada Arzneimittel, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Stada Arzneimittel with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
STADA ARZNEIMITTEL11331 - -
BOEHRINGER INGELHEIM3418389
NOVARTIS6472 - 21
PFIZER54984412